The ASCO Post, the #1 oncology newspaper, is a fundamental resource for busy clinicians who wish to stay informed about the rapidly changing field of oncology.
The ASCO Post, published by Harborside in partnership with the American Society of Clinical Oncology (ASCO), communicates news of evidence-based multidisciplinary cancer care to a broad audience of oncology professionals and ASCO members. It is the #1 oncology newspaper in the field (source: Kantar media).
Available in print and digital formats, The ASCO Post works to keep readers informed about the latest clinical oncology data. Under the guidance of James O. Armitage, MD, Editor-in-Chief, and a team of more than 40 editorial advisors from the United States and abroad, each issue features highly validated coverage of clinical cancer research and practice issues complemented by thoughtful commentary from leaders in the field of clinical oncology.
The ASCO Post also publishes The ASCO Post Evening News, a newsletter emailed to 23,075 U.S.-based and 11,394 international ASCO members nightly through the business week. It is a curated digest for health-care providers to quickly and accurately catch up on breaking news in the world of oncology.
The ASCO Post additionally produces The ASCO Post Newsreels, 2–3 minute video synopses of important research presented at major meetings.
Dr. Armitage graduated from the University of Nebraska Medical Center in 1973, and completed his internship and residency in internal medicine there in 1975. In 1977, he completed a fellowship in hematology/oncology at the University of Iowa Hospitals and Clinics, Iowa City, Iowa. He has served as Vice Chairman of the Department of Medicine (1982-90), Chief of the Division of Oncology/Hematology (1986-89), Chairman of the Department of Internal Medicine (1990-99), Dean, College of Medicine (2000-03), and presently holds the position of the Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center.
He is a member of several professional organizations and an editor of the Journal of Oncology Practice. He is a Fellow of the American College of Physicians, the Royal College of Physicians, and ASCO. He has served as President of ASCO (1996-97) and President of the American Society for Blood and Marrow Transplantation (2000-01). He has authored or co-authored over 500 articles, over 100 book chapters, and is the editor/co-editor of 27 books.
Dr. Armitage has been Editor-in-Chief of The ASCO Post since 2010.View Editorial Board
The ASCO Post is the most-read oncology newspaper in the market. The current circulation for the publication is 28,061, and its frequency is 24 issues per year. Bonus distribution is available at over a dozen live medical conferences each year.
Advertising opportunities exist in print, for the website, for electronic table of contents emails, for The ASCO Post Evening News, and more. Further details are available in the media kit and rate card. Please contact our advertising representatives with any inquiries. All advertisements are subject to ASCO's Advertising Policy.
National Accounts Representative, ASCO Publications
VP, Director of Advertising Sales, The ASCO Post
VP, Senior Accounts Manager, ASCO Publications